Aim: To estimate an effect of cellex on the dynamics and time of speech functions recovery in the acute stage of ischemic stroke.
Material And Methods: A multicenter, randomized, double-blind, placebo controlled clinical study included 8 Russian clinical sites. Four hundred eighty patients were involved. During the standard base therapy, cellex (or placebo) was introduced subcutaneously in dose 0,1 mg once a day in the first 10 days from the beginning of hospitalization.
Results And Conclusion: The rapid and complete regress of aphasia, especially in cases of severe and middle to severe clinical course, was observed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17116/jnevro20151159260-63 | DOI Listing |
Publication Analysis
Top Keywords
acute stage
8
stage ischemic
8
[possibilities treatment
4
treatment speech
4
speech impairment
4
impairment acute
4
ischemic stroke
4
stroke neuroprotective
4
neuroprotective therapy]
4
therapy] aim
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!